DNA X, Inc.
SONM · XNASCIK 1178697fmd_18EDF7HKTDQA017WW323V1Z2FAManufacturing · Telephone & Telegraph ApparatusTemplate: Standard
Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 136 | 116 | 64 | 55 | 70 | 94 | 58 | – |
| Cost of revenue | 88 | 82 | 49 | 48 | 58 | 74 | 48 | – |
| Gross profit | 48 | 35 | 15 | 6 | 12 | 19 | 10 | – |
| Provision for credit losses | – | – | – | – | 0 | 0 | 2 | – |
| Research and development | 23 | 26 | 16 | 18 | 8 | 2 | 14 | – |
| Selling, general and administrative | 19 | 29 | 20 | 20 | 18 | 17 | 25 | – |
| Total operating expenses | 43 | 57 | 44 | 44 | 26 | 19 | 3 | 5 |
| Operating income | 5 | (22) | (29) | (38) | (14) | 1 | (3) | (5) |
| Interest expense | – | – | – | – | 0 | – | – | 1 |
| Other non-operating income (expense) | (1) | (1) | (0) | (0) | 0 | (0) | 0 | (1) |
| Income before taxes | 2 | (24) | (30) | (38) | (14) | 0 | (3) | (8) |
| Income tax expense | 1 | 1 | (1) | 0 | 0 | 0 | 0 | (1) |
| Net income from continuing operations | 1 | (26) | (30) | (39) | (14) | (0) | (3) | (8) |
| Net income | 1 | (26) | (30) | (39) | (14) | (0) | (34) | (21) |
| Net income to common shareholders | (9) | (26) | – | – | – | – | – | – |